GDNF and inflammatory bowel disease: We observed a significant increase (p < 0.05) in the passage of 51Cr-EDTA through CD patients’ tissues stimulated with GSNO, GDNF, and GSNO/GDNF, respectively, compared to non-IBD control (Figure 6A).